Gilead Sciences to Present at the Deutsche Bank 38th Annual Health Care
Conference on Wednesday, May 29
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif. -- May 28, 2013
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the Deutsche Bank 38^th Annual Health Care
Conference in Boston.
Norbert W. Bischofberger, PhD, Gilead’s Executive Vice President, Research and
Development and Chief Scientific Officer, will provide an overview of the
company at the conference on Wednesday, May 29 at 10:00 a.m. Eastern Time.
To access the live webcast or a replay via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit www.gilead.com or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Press spacebar to pause and continue. Press esc to stop.